NASDAQ:PHAR
Pharming Group N.V.
- Stock
Last Close
0.91
26/04 16:35
Market Cap
788.51M
Beta: 0.95
Volume Today
580
Avg: 26.41K
PE Ratio
−37.26
PFCF: −31.36
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | 68.23M - | 47.47M 30.43% | 22.03M 53.58% | 14.99M 31.98% | -12.01M 180.15% | |
depreciation and amortization | 5.80M - | 8.95M 54.32% | 18.72M 109.20% | 13.19M 29.56% | 15.93M 20.75% | |
deferred income tax | -2.55M - | -721.22K 71.77% | -17.83M - | |||
stock based compensation | 7.04M - | 8.65M 22.87% | 6.39M 26.07% | 9.25M 44.73% | ||
change in working capital | 3.60M - | -3.26M 190.53% | -4.73M 45.33% | -387K 91.83% | -16.96M 4,282.69% | |
accounts receivables | ||||||
inventory | 3.44M - | -3.40M 198.88% | -5.87M 72.91% | -15.02M 155.64% | -14.43M 3.88% | |
accounts payables | ||||||
other working capital | 163.54K - | 138.98K 15.02% | 1.14M 719.53% | 14.63M 1,184.36% | -2.53M 117.27% | |
other non cash items | -3.07M - | 33.34M 1,186.22% | -7.82M 123.45% | -11.28M 44.34% | -13.51M 19.69% | |
net cash provided by operating activities | 74.56M - | 90.98M 22.03% | 36.13M 60.29% | 22.90M 36.62% | -17.30M 175.56% | |
investments in property plant and equipment | -25.44M - | -16.47M 35.27% | -15.96M 3.11% | -1.98M 87.61% | -1.46M 25.95% | |
acquisitions net | -2.80M - | -354.23K 87.37% | 7.30M - | |||
purchases of investments | -4.38M - | -382.01M - | ||||
sales maturities of investments | 232.81M - | |||||
other investing activites | 0.00 - | -0.00 - | 19.82M - | |||
net cash used for investing activites | -28.25M - | -16.82M 40.44% | -20.34M 20.89% | 5.32M 126.17% | -129.39M 2,530.73% | |
debt repayment | -37.38M - | -63.96M 71.09% | -3.15M 95.08% | -3.31M 5.19% | -5.13M 54.82% | |
common stock issued | 3.11M - | 3.00M 3.44% | 4.50M 49.89% | 2.28M 49.36% | ||
common stock repurchased | ||||||
dividends paid | ||||||
other financing activites | -28.05M - | 126.28M 550.19% | -28.03M 122.20% | -3.95M 85.90% | ||
net cash used provided by financing activities | -62.32M - | 65.33M 204.82% | -26.68M 140.84% | -4.98M 81.33% | -1.04M 79.14% | |
effect of forex changes on cash | 1.51M - | -15.54M 1,129.09% | 13.46M 186.60% | -7.82M 158.11% | 2.13M 127.21% | |
net change in cash | -14.50M - | 123.94M 954.53% | 2.57M 97.93% | 15.42M 500.68% | -145.60M 1,044.36% | |
cash at beginning of period | 91.31M - | 81.54M 10.70% | 189.16M 131.97% | 191.92M 1.46% | 207.34M 8.03% | |
cash at end of period | 76.81M - | 205.49M 167.54% | 191.72M 6.70% | 207.34M 8.15% | 61.74M 70.22% | |
operating cash flow | 74.56M - | 90.98M 22.03% | 36.13M 60.29% | 22.90M 36.62% | -17.30M 175.56% | |
capital expenditure | -25.44M - | -16.47M 35.27% | -15.96M 3.11% | -1.98M 87.61% | -1.46M 25.95% | |
free cash flow | 49.11M - | 74.51M 51.71% | 20.17M 72.93% | 20.92M 3.73% | -18.77M 189.70% |
All numbers in USD (except ratios and percentages)